Search Results - "Baghai, T."
-
1
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression
Published in Molecular psychiatry (01-11-2004)“…Tryptophan hydroxylase (TPH), being the rate-limiting enzyme in the biosynthesis of serotonin plays a major role as candidate gene in several psychiatric…”
Get full text
Journal Article -
2
Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side-Effect Profile
Published in Journal of neuroendocrinology (01-01-2012)“…Anxiety disorders are frequent and highly disabling diseases with considerable socio‐economic impact. In the treatment of anxiety disorders, benzodiazepines…”
Get full text
Journal Article Conference Proceeding -
3
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
Published in Neuroscience (15-09-2011)“…Abstract In the past decades considerable evidence has emerged that so-called neuroactive steroids do not only act as transcriptional factors in the regulation…”
Get full text
Journal Article -
4
Gut microbiota and depression : Pathophysiology of depression: hypothalamic-pituitary-adrenal axis and microbiota-gut-brain axis
Published in Nervenarzt (01-12-2020)“…Depression is a chronic disease with a complex multifactorial and still not fully clarified etiology. Due to new insights after recent investigations of the…”
Get full text
Journal Article -
5
Translocator Protein (TSPO) Expression in Platelets of Depressed Patients Decreases during Antidepressant Therapy
Published in Pharmacopsychiatry (01-09-2016)“…A promising candidate in the field of pharmacological treatment options regarding major depressive disorder (MDD) is the mitochondrial translocator protein (18…”
Get more information
Journal Article -
6
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism
Published in Molecular psychiatry (01-11-2006)“…Angiotensin-converting enzyme (ACE) is assumed to influence the activity of the hypothalamic-pituitary-adrenocortical (HPA) system, which shows hyperactivity…”
Get full text
Journal Article -
7
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression
Published in Molecular psychiatry (01-12-2008)“…The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult…”
Get full text
Journal Article -
8
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity
Published in Molecular psychiatry (01-03-2006)“…Concentrations of 3α-reduced neuroactive steroids are altered in depression and normalize after antidepressant pharmacotherapy with selective serotonin…”
Get full text
Journal Article -
9
Gut microbiome and major depressive disorder : The other side of ourselves
Published in Nervenarzt (01-11-2016)“…Microbiological ecology and its ambition to describe the complete genome of complex living communities as a whole, have given us powerful tools to characterize…”
Get full text
Journal Article -
10
St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy
Published in Pharmacopsychiatry (01-06-1998)“…In a randomized, double-blind, placebo-controlled, multicenter study, the clinical efficacy and safety of two different extracts of St. John's wort were…”
Get more information
Journal Article -
11
Neuroactive steroids as modulators of depression and anxiety
Published in Neuroscience (01-01-2006)“…Certain neuroactive steroids modulate ligand-gated ion channels via non-genomic mechanisms. Especially 3α-reduced pregnane steroids are potent positive…”
Get full text
Journal Article Conference Proceeding -
12
Neuroactive steroids and affective disorders
Published in Pharmacology, biochemistry and behavior (01-08-2006)“…Neuroactive steroids modulate neurotransmission through modulation of specific neurotransmitter receptors such as γ-aminobutyric acid type A (GABA A)…”
Get full text
Journal Article -
13
Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients
Published in Psychoneuroendocrinology (01-09-2006)“…Data suggest that both neurotrophic and hypothalamic–pituitary–adrenocortical (HPA) systems are involved in the pathophysiology of depression. The aim of the…”
Get full text
Journal Article -
14
Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic-Pituitary-Adrenal-Axis Activity: A Placebo-Controlled Study
Published in Neuropsychopharmacology (01-05-2003)“…Cholecystokinin-tetrapeptide (CCK-4) induces panic attacks both in patients with panic disorder (PD) and healthy volunteers. It has been shown that panic…”
Get full text
Journal Article -
15
Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4
Published in Current pharmaceutical design (01-11-2008)“…Pharmacological magnetic resonance imaging (phMRI) is a method to study effects of psychopharmacological agents on neural activation. Changes of the blood…”
Get more information
Journal Article -
16
Combined action of the ACE D- and the G-protein β3 T-allele in major depression : a possible link to cardiovascular disease?
Published in Molecular psychiatry (01-12-2002)“…Although it is well established that depression is a major risk factor for the development of coronary artery disease and that cerebrovascular disease can be a…”
Get full text
Journal Article -
17
Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder
Published in Pharmacopsychiatry (01-11-2009)“…There is evidence that a decreased GABAergic tone plays a role in the pathophysiology of panic disorder (PD). Selective GABAergic treatment has been suggested…”
Get more information
Journal Article -
18
S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations
Published in Nervenarzt (01-05-2012)“…Bipolar disorders are severe psychiatric disorders with extensive individual and health economic consequences. Starting in 2007 the first German evidence and…”
Get full text
Journal Article -
19
The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression
Published in Psychoneuroendocrinology (01-04-2003)“…Background: Hypothalamic-pituitary-adrenocortical (HPA) dysregulation assessed by the combined dexamethasone corticotropin releasing hormone test (DEX/CRH…”
Get full text
Journal Article -
20